Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
A8MV57
UPID:
MPTX_HUMAN
Alternative names:
-
Alternative UPACC:
A8MV57
Background:
The Putative mucosal pentraxin homolog, identified by the accession number A8MV57, represents a novel entity within the pentraxin family. Pentraxins are characterized by their role in the acute phase response and innate immunity, suggesting a potential involvement in mucosal defense mechanisms.
Therapeutic significance:
Understanding the role of Putative mucosal pentraxin homolog could open doors to potential therapeutic strategies. Its association with innate immunity highlights its potential as a target for modulating immune responses in disease conditions.